Pharma Journalist 8791 posts 0 comments

Hear from Amgen as they will be presenting the Keynote Address: Platform approach for combination products and devices on day one by Ronald Forster, Executive Director, Amgen and Kesley…
Read More...

Biotheque Wallonie Bruxelles to lead a workshop at the 9th Annual Biobanking Conference SMi Group are delighted to have the industry expert Laurent Dolle, Managing Director,…
Read More...

Highly Potent APIs 2019 Conference: Interview with Bayer Pharma Dr Ulrich Rüemenapp, Head of Launch Preparation and Coordination at Bayer Pharma, will be discussing late stage CMC…
Read More...

Forge Therapeutics, Inc. (Forge) and Basilea Pharmaceutica International Ltd. (Basilea), a wholly-owned subsidiary of Basilea Pharmaceutica Ltd., announced that they have entered into a…
Read More...

La Jolla Pharmaceutical Company announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for the New Investigational Drug Product,…
Read More...

Forbius, a clinical-stage company that develops novel biologics for the treatment of fibrosis and cancer, announced that the first patient has been dosed in a Phase 1b trial assessing…
Read More...

Knopp Biosciences LLC, a privately held drug discovery and development company focused on delivering breakthrough treatments for inflammatory and neurological diseases with high unmet…
Read More...

ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), and Adagene Inc., an antibody…
Read More...

The 7th Annual PREDiCT: Tumor Models Boston summit will be held on July 16 – 18 2019 in Boston, MA. For its anticipated return, Tumor Models Boston rebrands alongside its sister events…
Read More...

Velabs Therapeutics announced that it has entered into an agreement with Chiome Bioscience, Inc., Tokyo, to jointly discover modulatory and functional antibodies for one of Chiome’s…
Read More...